ICCC Stock - Immucell Corp.

ICCC Stock Chart

ICCC Profile

ImmuCell Corporation, headquartered in Portland, Maine, is a prominent player in the animal health industry, dedicated to developing, manufacturing, and marketing innovative products that enhance the health and productivity of dairy and beef cattle globally. Founded in 1982, the company focuses on addressing critical challenges in livestock management through its specialized product portfolio.

The cornerstone of ImmuCell's offerings includes First Defense, an orally administered scours preventive product designed for newborn dairy and beef calves. Additionally, Tri-Shield First Defense provides passive antibodies crucial for combating E. coli, coronavirus, and rotavirus infections in young calves, ensuring early protection against prevalent diseases.

ImmuCell further supports dairy farmers with essential diagnostic tools such as the California Mastitis Test, facilitating the detection of somatic cell counts in milk to pinpoint mastitis in specific udder quarters. The company also caters to the nutritional and feed supplement markets through products like Dual-Force First Defense, leveraging whey protein concentrate to enhance animal health and performance.

In its commitment to advancing livestock health, ImmuCell is actively developing Re-Tain, an intramammary treatment utilizing Nisin for subclinical mastitis in lactating dairy cows. By collaborating closely with animal health distributors, ImmuCell ensures its products reach a broad customer base both domestically and internationally, thereby reinforcing its leadership in promoting animal welfare and productivity across global agricultural markets.

ICCC Revenue Chart

ICCC Earnings

Analyst Ratings